Dysfunctional T regulatory cells in multiple myeloma

被引:200
作者
Prabhala, RH
Neri, P
Bae, JE
Tassone, P
Shammas, MA
Allam, CK
Daley, JF
Chauhan, D
Blanchard, E
Thatte, HS
Anderson, KC
Munshi, NC
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Vet Adm Boston Healthcare Syst, Boston, MA 02115 USA
[3] Univ Magna Graecia, Catanzaro, Italy
[4] Ctr Canc, Catanzaro, Italy
关键词
D O I
10.1182/blood-2005-08-3101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple myeloma (MM) is characterized by the production of monoclonal immunoglobulin and is associated with suppressed uninvolved immunoglobulins and dysfunctional T-cell responses. The biologic basis of this dysfunction remains ill defined. Because T regulatory (T-reg) cells play an important role in suppressing normal immune responses, we evaluated the potential role of Treg cells in immune dysfunction in MM. We observed a significant increase in CD4(+)CD25(+) T cells in patients with monoclonal gammopathy of undetermined significance (MGUS) and in patients with MM compared with healthy donors (25% and 26%, respectively, vs 14%); however, T-reg cells as measured by FOXP3 expression are significantly decreased in patients with MGUS and MM compared with healthy donors. Moreover, even when they are added in higher proportions, T-reg cells in patients with MM and MGUS are unable to suppress anti-CD3-mediated T-cell proliferation. This decreased number and function of T-reg cells in MGUS and in MM may account, at least in part, for the nonspecific increase in CD4(+)CD25(+) T cells, thereby contributing to dysfunctional T-cell responses.
引用
收藏
页码:301 / 304
页数:4
相关论文
共 29 条
[1]  
AMULF B, 2002, ARCH INTERN MED, V162, P464
[2]   Haematopoietic malignancies in rheumatoid arthritis:: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists [J].
Askling, J ;
Fored, CM ;
Baecklund, E ;
Brandt, L ;
Backlin, C ;
Ekbom, A ;
Sundström, C ;
Bertilsson, L ;
Cöster, L ;
Geborek, P ;
Jacobsson, LT ;
Lindblad, S ;
Lysholm, J ;
Rantapää-Dahlqvist, S ;
Saxne, T ;
Klareskog, L ;
Feltelius, N .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1414-1420
[3]   Suppressor T cells in human diseases [J].
Baecher-Allan, C ;
Hafler, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) :273-276
[4]   Natural regulatory T cells in infectious disease [J].
Belkaid, Y ;
Rouse, BT .
NATURE IMMUNOLOGY, 2005, 6 (04) :353-360
[5]   Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine [J].
Beyer, M ;
Kochanek, M ;
Darabi, K ;
Popov, A ;
Jensen, M ;
Endl, E ;
Knolle, PA ;
Thomas, RK ;
von Bergwelt-Baildon, M ;
Bebey, S ;
Hallek, M ;
Schultze, JL .
BLOOD, 2005, 106 (06) :2018-2025
[6]   Natural versus adaptive regulatory T cells [J].
Bluestone, JA ;
Abbas, AK .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :253-257
[7]   Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10 [J].
Brown, RD ;
Pope, B ;
Murray, A ;
Esdale, W ;
Sze, DM ;
Gibson, J ;
Ho, PJ ;
Hart, D ;
Joshua, D .
BLOOD, 2001, 98 (10) :2992-2998
[8]   Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood [J].
Dieckmann, D ;
Plottner, H ;
Berchtold, S ;
Berger, T ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1303-1310
[9]   The IL-6R α chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo [J].
Doganci, A ;
Eigenbrod, T ;
Krug, N ;
De Sanctis, GT ;
Hausding, M ;
Erpenbeck, VJ ;
Haddad, EB ;
Schmitt, E ;
Bopp, T ;
Kallen, KJ ;
Herz, U ;
Schmitt, S ;
Luft, C ;
Hecht, O ;
Hohlfeld, JM ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Kishimoto, T ;
Rose-John, S ;
Renz, H ;
Neurath, MF ;
Galle, PR ;
Finotto, S .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :313-325
[10]   A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 [J].
Fontenot, JD ;
Rudensky, AY .
NATURE IMMUNOLOGY, 2005, 6 (04) :331-337